Soligenix, Inc. SNGXW 深 滬
交易中 07-23 11:33:25 美东时间
0.009
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.009
- 總市值 36.02万
- 52周最高 0.82
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.008
- 委 比 0.00%
- 總股本 4002.05万
- 歷史最高 1.314
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.00
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Soligenix Halts HyBryte Program, Refocuses Pipeline Strategy
Soligenix ( ($SNGX) ) just unveiled an update. On June 10, 2026, Soligenix rece...
06-13 05:05
Soligenix To Apply For Bundibugyo Ebola Vaccine Development Funding
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, noted
06-08 19:34
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Thermostability, immunogenicity and efficacy data against related viruses provides firm starting point for rapid vaccine development PRINCETON, N.J., June 8, 2026 /PRNewswire/ -- Soligenix, ...
06-08 19:30
Soligenix Expands At-The-Market Equity Financing Capacity
Soligenix ( ($SNGX) ) has issued an announcement. On May 28, 2026, Soligenix, I...
05-29 07:15
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares rose 7% in pre-market trading as Q2 guidance exceeded expectations.
05-27 17:10
Soligenix GAAP EPS of $0.28
Soligenix press release (SNGX): Q1 GAAP EPS of $0.28. Research and development expenses were $1.8 million as compared to $1.9 million for the quarter ended March 31, 2026 and 2025, respectively. The d...
05-08 19:44
Soligenix Q1 EPS $(0.28), Inline
Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This is a 73.58 percent increase over losses of $(1.06) per share from the same period last year.
05-08 19:38
